Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SRA737 |
Trade Name | |
Synonyms | CCT245737|CCT-245737 |
Drug Descriptions |
SRA737 (CCT245737) is a selective oral inhibitor of CHK1, which may enhance sensitivity of tumor cells to chemotherapeutics, thereby resulting in increased antitumor activity (PMID: 27167172, PMID: 31470128). |
DrugClasses | CHK1 Inhibitor 18 |
CAS Registry Number | 1489389-18-5 |
NCIT ID | C129580 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gemcitabine + SRA737 | Gemcitabine SRA737 | 0 | 0 |
SRA737 | SRA737 | 0 | 0 |
SRA737 + STP-B | SRA737 STP-B | 0 | 0 |